A number of potential CodeX Use Cases which are now in the Discovery phase. These are Use Cases that promise to substantially improve cancer care and research through community alignment around the use of mCODE™ and necessary extensions for sharing of standard, structured cancer data. Current and prospective CodeX members are reviewing and building out the ideas listed in the table below. CodeX members will prioritize and ultimately select use cases for development based on:
- Their potential impact to fill a compelling and urgent need (value)
- How quickly value can be demonstrated through implementation and pilots (speed)
- How excited the community is to lead and participate (community drive)
We are also launching the mCODE Community of Practice as a proto-use-case around routine data collection and sharing of mCODE-based data through EHRs and other systems.
Use Cases in the Discovery Phase
|mCODE Community of Practice||The mCODE Community of Practice is a group of health systems and other CodeX members working together to improve cancer care and research by developing best practices for implementing mCODE into production EHRs and other systems to improve cancer care and research.||Participants in the CoP will become better equipped to leverage mCODE in health data systems for a variety of purposes, including use cases like those below.|
|Empowering Patients to Find Clinical Trials||Improve capability for patients to find clinical trials for which they may be eligible.||Define and structure key trial enrollment criteria; incorporate into EHR and structured patient reported data workflows to improve reliability and automated matching capabilities, reducing manual data entry to find potential clinical trials.|
|Registry Reporting||Enable low-burden, standardized reporting of cancer data from cancer centers to registries that are aggregating data for different reasons.||Consider use of mCODE and extensions for registry reporting to assess cross-center standards of care, starting with CAR-T therapy. Other potential scenarios could expand scope to support population health, clinical trials, post-market surveillance, quality reporting, comparative effectiveness and more.|
Enable clinicians to use an oncology clinical pathway application that accurately navigates to recommended treatments using structured data in the EHR.
|Define and structure clinical oncology data required to evaluate branch-points. Use mCode and CodeX to define data elements and incorporate the new data into existing workflows.|
Enable automatic exchange of clinical oncology data recorded by providers, to payers.
|Da Vinci HL7 FHIR Accelerator has developed a solution for the generic use case. This use case extends the generic use case with mCODE and CodeX for provider-payer data exchange in support of care for cancer patients.|
|EHR Endpoints for Clinical Trials|
Reduce and potentially eliminate manual and/or duplicate data entry into care case report forms (CRF).
|Use clinical treatment data captured in the EHR to derive and/or compute clinical trial endpoints. mCODE and CodeX extensions support this data. Scenarios of interest include CAR-T therapies, rare diseases and others.|
|Alternative Payment Model Data Reporting||Facilitate clinical practice reporting to registries and payer repositories governed by oncology payment models, such as chemotherapy episodes.||Define and structure oncology APM required data using mCODE and CodeX extensions; incorporate into EHR workflows.|
|Drug Value Based Agreements||Operationalize drug value based agreements for clinicians, payers, and pharma.||Define and structure relevant real world data using mCODE and CodeX extensions to enable collection in EHRs, making it available for automated outcome evaluation.|
|Radiation Therapy Data for Care Coordination and Data Reuse|
Enable sharing of critical radiation therapy summary data for care coordination or data reuse (research, quality measurement, payer-required reporting).
|Provider shares radiation therapy oncology treatment summary data with other providers, patients and authorized receivers. mCODE and potential CodeX data elements are incorporated into the radiation oncology workflows.|